|
|
Volumn 11, Issue 8, 2002, Pages 1023-1032
|
|
Reversing antibiotic resistance
|
|
Author keywords
Multi drug resistance; Multidrug resistance reversal agents; Multiple resistance protein; P glycoprotein; P glycoprotein inhibitors
|
|
Indexed keywords
2,4 BIS(ALLYLAMINO) 6 [4 [[2,2 BIS(4 FLUOROPHENYL)ETHYL]AMINO]PIPERIDINO] 1,3,5 TRIAZINE;
ANTINEOPLASTIC ANTIBIOTIC;
CALCIUM CHANNEL BLOCKING AGENT;
CHLOROQUINE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
CYTARABINE;
DAUNORUBICIN;
DEXAMETHASONE;
DEXNIGULDIPINE;
DEXVERAPAMIL;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FANTOFARONE;
GLYCOPROTEIN P;
GLYCOPROTEIN P INHIBITOR;
METHACRYLIC ACID DERIVATIVE;
MITOXANTRONE;
MULTIDRUG RESISTANCE PROTEIN 1;
PREDNISOLONE;
PROTEIN INHIBITOR;
QUINIDINE;
QUININE;
TAMOXIFEN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VALSPODAR;
VERAPAMIL;
VINBLASTINE;
VINCRISTINE;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LYMPHOCYTIC LEUKEMIA;
ANOREXIA;
ANTIBIOTIC RESISTANCE;
AREA UNDER THE CURVE;
BREAST CANCER;
CANCER CELL CULTURE;
CANCER REGRESSION;
CANCER SURVIVAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG POTENTIATION;
DRUG PROTEIN BINDING;
DRUG RESEARCH;
EDITORIAL;
HUMAN;
HYPOTENSION;
KIDNEY CARCINOMA;
MALARIA;
MULTIDRUG RESISTANCE;
NAUSEA;
NEUROBLASTOMA;
OSTEOSARCOMA;
PLASMODIUM FALCIPARUM;
PROTEIN EXPRESSION;
PROTEIN STRUCTURE;
SIDE EFFECT;
ANTI-BACTERIAL AGENTS;
BREAST NEOPLASMS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
GENES, MDR;
HUMANS;
P-GLYCOPROTEIN;
TAMOXIFEN;
TREATMENT OUTCOME;
|
|
EID: 0036046059
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.11.8.1023 Document Type: Editorial |
|
Times cited : (8)
|
|
References (34)
|
